Thermoablation of atrial fibrillation. In the 1990s, Liryc's clinicians identified the sources of atrial fibrillation in the pulmonary veins. This discovery helped to develop a curative treatment for this disorder. It involves cauterising the pulmonary veins with a radiofrequency catheter to isolate these sources of arrhythmia. This treatment has become the standard treatment: to date, more than 300,000 patients benefit from it each year worldwide.
Thermoablation of ventricular fibrillation. The clinicians also highlighted the sources of sudden death from ventricular fibrillation. These sources are located in the heart's electrical system, called the Purkinje network. This electrical network is essential for cardiac contraction and only represents 2% of the heart’s ventricular mass. Destruction of these sources of arrhythmia by thermoablation represents an innovative and curative approach to ventricular fibrillation in order to prevent sudden death.
The clinicians also practise cryotherapy ablation procedures in some cases of atrial fibrillation.